Scientists identify two more hybrid variants alongside Deltacron
The hybrid of Delta and Omicron, known as ‘Deltacron’, has been identified in France, Denmark and the Netherlands
Read More
Author: John Pinching
Waiting game: a record 6.1 million NHS patients are currently waiting for non-urgent treatment
The NHS has not met the 18-week target for people to receive planned treatment in England since February 2016
Read More
Omicron BA.2 variant triggers COVID-19 surge in England
The sub-variant combines mutations from both Omicron and Delta
Read More
Severe COVID-19 linked to risk of mental health effects
Patients who were bedridden for seven days or longer were at increased risk of depression and anxiety over the study period
Read More
NICE to improve diagnosis for foetal alcohol spectrum disorder
Better treatment for conditions experienced by individuals who were exposed to alcohol before birth
Read More- Pierre Fabre Laboratories secures CHMP backing for first‑line BRAFTOVI regimen
- Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis
- KOALA trial opens to enrol patients for first‑in‑human KMCAR T‑cell therapy
- Pepaxti study supports use in wider myeloma population
- UCB reports positive outcomes for bimekizumab in psoriatic arthritis
